Pay in 4 interest-free payments of $5.50 Learn more
Ships within 48 hours · Estimated delivery Sep 3 - Sep 8
Preclinical studies in mice demonstrate significant reductions in fat mass and body weight without changes in food intake
Notably, FOXO4-DRI treatment did not cause significant changes in body weight or testis weight, suggesting a targeted effect [1]
AOD-9604 is a modified fragment of human growth hormone (hGH), specifically designed to target fat reduction without the growth-promoting effects of traditional hGH
PMID 12147369
In February 2026, the U.S
US$ 26.19
US$ 29.45
US$ 22.69
US$ 22.09
US$ 27.33
US$ 23.87
US$ 25.88
US$ 22.00
US$ 27.73
US$ 20.47
